Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Schwartz, J. Costentin, M. Martres, P. Protais, M. Baudry (1978)
Modulation of receptor mechanisms in the CNS: Hyper-and hyposensitivity to catecholaminesNeuropharmacology, 17
O. Lowry, N. Rosebrough, A. Farr, R. Randall (1951)
Protein measurement with the Folin phenol reagent.The Journal of biological chemistry, 193 1
E. Pich, F. Benfenati, C. Farabegoli, K. Fuxe, E. Meller, Marie Aronsson, M. Goldstein, L. Agnati (1987)
Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockadeBrain Research, 435
L. Selbie, G. Hayes, J. Shine (1989)
The major dopamine D2 receptor: molecular analysis of the human D2A subtype.DNA, 8 9
F. Monsma, L. McVittie, C. Gerfen, L. Mahan, D. Sibley (1989)
Multiple D2 dopamine receptors produced by alternative RNA splicingNature, 342
B. Giros, P. Sokoloff, M. Martres, J. Riou, L. Emorine, J. Schwartz (1989)
Alternative splicing directs the expression of two D2 dopamine receptor isoformsNature, 342
K. Neve, Steve Loeschen, J. Marshall (1985)
Denervation accelerates the reappearance of neostriatal D-2 receptors after irreversible receptor blockadeBrain Research, 329
D. Burt, D. Burt, I. Creese, SolomonH Snyder (1977)
Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.Science, 196 4287
(1977)
Long - term changes in the sensitivity of 150 - 1 51
Yves Agid, F. Javoy, Jacques Glowinski (1973)
Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat.Nature: New biology, 245 144
M. Martres, J. Costentin, M. Baudry, H. Marcais, P. Protais, J.-C. Schwartz (1977)
Long-term changes in the sensitivity of pre- and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studiesBrain Research, 136
H. Tol, M. Riva, O. Civelli, I. Creese (1990)
Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA levelNeuroscience Letters, 111
C. Strader, I. Sigal, R. Dixon (1989)
Mapping the Functional Domains of the β-adrenergic ReceptorAmerican Journal of Respiratory Cell and Molecular Biology, 1
J. Schwartz, M. Baudry, M. Martres, J. Costentin, P. Protais (1978)
Increased in vivo binding of 3H-pimozide in mouse striatum following repeated administration of haloperidol.Life sciences, 23 17-18
J. Costentin, P. Protais, J. Schwartz (1975)
Rapid and dissociated changes in sensitivities of different dopamine receptors in mouse brainNature, 257
H. Aviv, P. Leder (1972)
Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.Proceedings of the National Academy of Sciences of the United States of America, 69 6
P. Chomczyński, N. Sacchi (1987)
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.Analytical biochemistry, 162 1
I. Creese, D. Sibley (1981)
Receptor adaptations to centrally acting drugs.Annual review of pharmacology and toxicology, 21
R. Toso, B. Sommer, M. Ewert, A. Herb, D. Pritchett, A. Bach, B. Shivers, P. Seeburg (1989)
The dopamine D2 receptor: two molecular forms generated by alternative splicing.The EMBO Journal, 8
D. Autelitano, L. Snyder, S. Sealfon, J. Roberts (1989)
Dopamine D2-receptor messenger RNA is differentially regulated by dopaminergic agents in rat anterior and neurointermediate pituitaryMolecular and Cellular Endocrinology, 67
I. Creese, D. Burt, D. Burt, SolomonH Snyder (1977)
Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity.Science, 197 4303
M. Bouthenet, M. Martres, N. Salès, J. Schwartz (1987)
A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulprideNeuroscience, 20
J. Costentin, Hélène Marcias, P. Protais, M. Baudry, S. Baume, M. Martres, J. Schwartz (1977)
Rapid development of hypersensitivity of striatal dopamine receptors induced by alpha-methylparatyrosine and its prevention by protein synthesis inhibitors.Life sciences, 21 3
M. Martres, M. Bouthenet, N. Salès, P. Sokoloff, J. Schwartz (1985)
Widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpride, a highly selective ligand.Science, 228 4700
C. Moine, E. Normand, A. Guitteny, B. Fouqué, R. Teoule, B. Bloch (1990)
Dopamine receptor gene expression by enkephalin neurons in rat forebrain.Proceedings of the National Academy of Sciences of the United States of America, 87 1
A. Norman, G. Battaglia, tan Creese (1987)
Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: a key to receptor regulatory mechanisms, 7
P. Sokoloff, B. Giros, M. Martres, M. Bouthenet, J. Schwartz (1990)
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 347
J. Kebabian, D. Calne (1979)
Multiple receptors for dopamineNature, 277
(1970)
The Rat Brain. A Stereofaxic Atlas
S. Soderland, Y. Naum (1973)
Growth of Pulmonary Alveolar Macrophages in vitroNature, 245
J. Chirgwin, A. Przybyla, Raymond MacDonald, W. Rutter (1979)
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.Biochemistry, 18 24
J. Goss, A. Kelly, S. Johnson, D. Morgan (1991)
Haloperidol treatment increases D2 dopamine receptor protein independently of RNA levels in mice.Life sciences, 48 10
J. Bunzow, H. Tol, D. Grandy, P. Albert, J. Salon, M. Christie, C. Machida, K. Neve, O. Civelli (1988)
Cloning and expression of a rat D2 dopamine receptor cDNANature, 336
Abstract: We examined the effects of an interruption of dopamine neurotransmission, by either dopamine receptor blockade or degeneration of dopamine neurons by 6‐hydroxydopamine, on the levels of D2 receptor mRNAs. In addition, we evaluated by the polymerase chain reaction (PCR) the relative abundance of the two D2 receptor isoform mRNAs generated by alternative splicing. Daily injections of 4 mg/kg of haloperidol to rats elicited in striatum a rapid and progressive increase in D2 receptor mRNA levels, which reached 70% after a 15‐day treatment. By contrast, there was no apparent change in D2 receptor mRNA levels in cerebral cortex and pons‐medulla, in spite of an increased density of D2 receptor in the former tissue. Using the PCR with primers flanking the alternative exon, we observed that the relative proportion of the shorter receptor isoform (D2s) mRNA was slightly but significantly enhanced in cerebral cortex (17%) and pons‐medulla (18%) after a 15‐day haloperidol treatment. Unilateral degeneration of dopamine neurons induced by local injection of 6‐hydroxydopamine resulted in a marked decrease in levels of total D2 receptor mRNAs in substantia nigra (—79%) and ventral tegmental (—63%) area, two cell body areas. In the substantia nigra, the longer isoform (D2l) mRNA was significantly more decreased in content than the D2s isoform mRNA, so that there was a large enhancement in the relative abundance of the latter (81%). In contrast, the lesion did not result in any significant change in levels of total D2 receptor mRNAs in striatum, but the relative proportion of D2s receptor mRNA tended to decrease—although nonsignificantly—as a result of a tendency of the D2l receptor mRNA abundance to rise. The present study establishes that two distinct processes of D2 receptor gene expression accompany and may contribute to the hypersensitivity known to develop at D2 receptors following either their chronic blockade by neuroleptics or dopamine denervation.
Journal of Neurochemistry – Wiley
Published: Feb 1, 1992
Access the full text.
Sign up today, get DeepDyve free for 14 days.